NCT07444983 2026-03-03
Rezvilutamide for High-Risk Prostate Cancer After Surgery
Fujian Medical University Union Hospital
Phase NA Not yet recruiting
Fujian Medical University Union Hospital
Stanford University
Lee's Pharmaceutical Limited
Urology of Virginia
Abbott